Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups

These days success and challenges of vaccines on infants, children, pregnant women and elderly patient is major concern for influenza research. Evidence-based guidelines for immunization of infants, children, adolescents, and adults have been prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). These guidelines are prepared for health care professionals who care for either immunocompetent or immunocompromised people of all ages. Vaccine innovation and human health researchers try to determine how well flu vaccines work to regularly assess and confirm the value of flu vaccination as a public health intervention in each season. Study results about how well a flu vaccine works can vary based on study design, outcome(s) measured, population studied and the season in which the flu vaccine was studied. These differences can make it difficult to compare one study’s results with another’s. rough the support of the U.S. Department of Health and Human Services and NIAID, researchers are developing various influenza vaccine delivery technologies that will help the United States and the world be better prepared to mount a speedy response to the next pandemic

Influenza is a serious disease that can lead to hospitalization and sometimes even death. Two types of influenza vaccines include the injection containing killed virus and nasal spray vaccines which containing live but weakened virus. The effectiveness of the flu vaccine is dependent upon the extent of the match between the virus strains used to prepare the vaccine and those viruses in actual circulation. Two factors age and health status of the individual play important role in determining the effectiveness of the vaccine. The vaccine is usually recommended for everyone 6 months of age or older. Anyone at risk for developing serious complications from the flu should also receive the flu vaccine, including pregnant women, people over 65, and individuals with chronic diseases and their caregivers. The vaccine is not recommended for people who have allergies to chicken eggs or people who have had an allergic reaction to the shot in the past.

  • Vaccine innovation and human health
  • Effectiveness of multivalent vaccines
  • Developing a universal flu vaccine
  • Success and challenges of vaccines on infants, children, pregnant women and elderly patient
  • Various influenza vaccine delivery technologies

Related Conference of Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups

August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
November 06-07, 2017

3rd International Conference on Flu and Emerging Infectious Diseases

Las Vegas, Nevada, USA
December 07-08, 2017

EuroSciCon Conference on STD-AIDS

Rome, Italy
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
June 11-12, 2018

4th World Congress on Rare Diseases and Orphan Drugs

Dublin, Ireland
August 13-14,2018

Global Experts Meeting on Infectious Diseases

Tokyo,Japan
31st August-1st September 2018

International Conference on Emerging Infectious Diseases

Zurich, Switzerland

Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups Conference Speakers

Recommended Sessions

Related Journals

Are you interested in